Home » Topics » Regulatory » EMA

EMA
RSS

Novo Nordisk's NovoEight gets positive opinion in E.U.

Sep. 23, 2013

Otsuka and Lundbeck receive positive CHMP opinion for Abilify Maintena

Sep. 23, 2013

EMA committee issues positive opinion on AstraZeneca's four-strain flu vaccine

Sep. 23, 2013

Relvar Ellipta receives approval in Japan, recommendation in Europe

Sep. 20, 2013

EMA grants orphan drug status to GMI-1070 in sickle cell disease

Sep. 17, 2013

EMA grants orphan drug designation to Patrys antibody for multiple myeloma

Sep. 12, 2013

EMA extends review of Clinuvel's SCENESSE to January 2014

Aug. 6, 2013

Novartis receives positive CHMP opinion for Ilaris in systemic juvenile idiopathic arthritis

July 31, 2013

EMA's CHMP issues positive opinion regarding afatinib

July 31, 2013

Simponi gets positive opinion in Europe for ulcerative colitis

July 30, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...